Showing 1 - 16 results of 16 for search 'Rikke Fredslund Andersen', query time: 0.04s
Refine Results
-
1
-
2
-
3
-
4
Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab by Torben Frøstrup Hansen, Rikke Fredslund Andersen, Dorte Aalund Olsen, Flemming Brandt Sørensen, Anders Jakobsen
Published 2017-05-01
Article -
5
The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab by Line Bechsgaard Andersen, Marit Sofie Kjær Mahler, Rikke Fredslund Andersen, Lars Henrik Jensen, Louise Raunkilde
Published 2022-09-01
Article -
6
-
7
-
8
-
9
Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification by Patricia Diana Sørensen, Rikke Fredslund Andersen, Niels Pallisgaard, Jonna Skov Madsen, Erik Hugger Jakobsen, Ivan Brandslund
Published 2015-08-01
Article -
10
Quantification of Cell-free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification by Patricia Diana Sørensen, Rikke Fredslund Andersen, Niels Pallisgaard, Jonna Skov Madsen, Erik Hugger Jakobsen, Ivan Brandslund
Published 2015-08-01
Article -
11
Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer by Louise Faaborg, Rikke Fredslund Andersen, Marianne Waldstrøm, Jon Røikjær Henriksen, Parvin Adimi, Anders Jakobsen, Karina Dahl Steffensen
Published 2022-03-01
Article -
12
MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer. by Anne Haahr Mellergaard Eriksen, Rikke Fredslund Andersen, Niels Pallisgaard, Flemming Brandt Sørensen, Anders Jakobsen, Torben Frøstrup Hansen
Published 2016-01-01
Article -
13
<i>NPY</i> Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer by Louise Raunkilde, Torben Frøstrup Hansen, Rikke Fredslund Andersen, Birgitte Mayland Havelund, Caroline Brenner Thomsen, Lars Henrik Jensen
Published 2022-09-01
Article -
14
Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients by Morten Borg, Sara Witting Christensen Wen, Torben Frøstrup Hansen, Anders Jakobsen, Rikke Fredslund Andersen, Ole Hilberg, Ulla Møller Weinreich, Line Nederby
Published 2022-06-01
Article -
15
Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA by Ina Mathilde Kjær, Søren Kahns, Signe Timm, Rikke Fredslund Andersen, Jonna Skov Madsen, Erik Hugger Jakobsen, Tomasz Piotr Tabor, Anders Jakobsen, Troels Bechmann
Published 2023-05-01
Article -
16
<i>NPY</i> Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer by Lars Henrik Jensen, René Olesen, Lone Noergaard Petersen, Anders Kindberg Boysen, Rikke Fredslund Andersen, Jan Lindebjerg, Lise Nottelmann, Caroline Emilie Brenner Thomsen, Birgitte Mayland Havelund, Anders Jakobsen, Torben Frøstrup Hansen
Published 2019-10-01
Article